SFX by Ex Libris Inc.

Title:	Resistance to therapy caused by intragenic deletion in BRCA2
Source:	Nature [0028-0836] Edwards, S L yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sakai, W. "Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers." Nature 451.7182 (2008): 1116-20.
description	2.	Greer, Julia B B. "Role of BRCA1 and BRCA2 mutations in pancreatic cancer." Gut 56.5 (2007): 601-605.
description	3.	Tavazoie, Sohail F F. "Endogenous human microRNAs that suppress breast cancer metastasis." Nature 451.7175 (2007): 147-52.
description	4.	Smalley, Matthew J S. "BRCA1 and stem cells: tumour typecasting." Nature cell biology 10.4 (2008): 377-9.
description	5.	Lord, Christopher J J. "RAD51, BRCA2 and DNA repair: a partial resolution." Nature structural & molecular biology 14.6 (2007): 461-2.
description	6.	Livingston, D. "Cancer - Crossing over to drug resistance." Nature 451.7182 (2008): 1066-1067.
description	7.	Swisher, Elizabeth M M. "Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance." Cancer research 68.8 (2008): 2581-6.
description	8.	Turke, Alexa B. "MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors." Cancer research 72.13 (2012): 3228-3237.
description	9.	Zhang, X. "Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface." Nature 450.7170 (2007): 741-4.
description	10.	Samimi, G. "Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells." Clinical cancer research 10.14 (2004): 4661-9.
description	11.	Ferrone, Cristina R. "BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma." Journal of clinical oncology 27.3 (2009): 433-8.
description	12.	Gylling, A. "Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors." Carcinogenesis 29.7: 1351-9.
description	13.	Mullins, Richard J C. "Diagnosis and management of blunt pancreatic ductal injury in the era of high-resolution computed axial tomography." The American journal of surgery 193.5 (2007): 641-3.
description	14.	Lynch, Henry T T. "BRCA1 and pancreatic cancer: pedigree findings and their causal relationships." Cancer genetics and cytogenetics 158.2 (2005): 119-25.
description	15.	Friedman, Rita M C. "Reproductive issues for women with BRCA mutations." Journal of the National Cancer Institute. Monographs Monographs..34 (2005): 83-6.
description	16.	Li, G. "The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis." Nature cell biology 10.2 (2008): 202-10.
description	17.	Feldstein, J. "Tumour invasion and metastasis initiated by microRNA-10b in breast cancer." Nature 449.7163 (2007): 682-8.
description	18.	Cho, W. "OncomiRs: the discovery and progress of microRNAs in cancers." Molecular cancer 6.1 (2007): 60-60.
description	19.	Almouzni, Genevive A. "The histone chaperone Asf1 is dispensable for direct de novo histone deposition in Xenopus egg extracts." Chromosoma 116.5 (2007): 487-496.
description	20.	Ashworth, S. J. "A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D." Oncogene 27.8: 1036-1044.